+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Orthopedic Implants Market By Product Type, By Biomaterial, By Type: Global Opportunity Analysis and Industry Forecast, 2022-2032

  • PDF Icon

    Report

  • 210 Pages
  • January 2023
  • Region: Global
  • Allied Market Research
  • ID: 5751064
The global orthopedic implants market was valued at $47,190.57 million in 2022 and is estimated to reach $73,326.75 million by 2032, exhibiting a CAGR of 4.5% from 2023 to 2032.

Orthopedic implants are medical devices used to replace or support the damaged or missing bones in the body. Orthopedic implants are divided into two groups such as permanent implants and temporary implants. Permanent orthopedic implants are used for hip, knee, ankle, shoulder, elbow, wrist, and finger joints, which are present in the human body throughout the life span of an individual.

Further, temporary orthopedic implants include plates, screws, pins, wires, and intramedullary nails, which are present for shorter periods just long enough to let the bones heal. Orthopedic implants are used to treat a variety of conditions such as osteoarthritis, fractures, and spinal disorders. Orthopedic implants include joint replacements (such as hip and knee replacement), spinal fusion devices, plates and screws used to stabilize fractures. They are made of materials such as metals, plastics, ceramic, and various polymers.

The major factors driving the growth of the orthopedic implants market are increase in incidences of osteoarthritis and other degenerative diseases, technological advancements that allow more effective and long-lasting implants and rise in geriatric population. In addition, a rise in the number of sports-related injuries is also expected to drive the growth of the market.

For instance, according to report published by the National Safety Council of the U.S. 2022 stated that in 2021, 20% rise in sports and recreational injuries was observed as compared to 2020, thus a rise in number of sport related injuries is expected to drive the growth of the market. Further, geriatric population is prone to develop and diagnose orthopedicdiseases such as arthritis, dislocation of bones and fractures, thus rise in geriatric population is anticipated to drive the growth of the market.

For instance, according to an article published by American Geriatric Society 2021 stated that 60 million people in the U.S. are aged 65 years or above and 80% of these population suffer from musculoskeletal conditions, thus rise in geriatric population drives the growth of orthopedic implant market. In addition, the rise in technological innovations in orthopedic implants, rise in adoption of orthopedic implants and improvement of healthcare infrastructure in the emerging countries, further supplement the growth of orthopedic implant market.

However, the high cost associated with procedures involving orthopedic implants treatment is the factor which hampers the growth of orthopedic implants market. In addition, stringent government policies regarding implants and their procedures are also expected to restrain the growth of the market. Furthermore, the rise in demand for orthopedic implants and rise in technological advancements are the factors which offer lucrative opportunities to the key players of orthopedic implants market. The global orthopedic implants market is segmented into product, type, biomaterial, and region. On the basis of product, the market is categorized into reconstructive joint replacements, spinal implants, dental implants, trauma, orthobiologics, and others. The reconstructive joint replacements segment is segmented into knee replacement implants, hip replacement implants, and extremities that include upper extremity reconstruction and lower extremity reconstruction.

In addition, spinal implants segment is further divided into spinal fusion implants, vertebral compression fracture (VCF) devices, and motion preservation devices/non-fusion devices. Furthermore, dental implants are again classified into root form dental implants and plate form dental implants. Moreover, orthobiologics is further segmented into demineralized bone matrix (DBM), allograft, bone morphogenetic protein (BMP), viscosupplementation products, synthetic bone substitutes, and others.

On the basis of type, the market is classified into knee, hip, wrist & shoulder, dental, spine, ankle, and others. On the basis of biomaterial, the market is categorized into metallic biomaterials, ceramic biomaterials, polymers biomaterials, and others. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

Major key players that operate in the global orthopedic implants market are Arthrex, Inc., Colfax Corporation (DJO, LLC), CONMED CORPORATION, GLOBUS MEDICAL INC., Johnson & Johnson (DEPUY SYNTHES), Medtronic Plc, NuVasive Inc., Smith & Nephew plc, Stryker Corporation, and Zimmer Biomet Holdings Inc.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the orthopedic implants market analysis from 2022 to 2032 to identify the prevailing orthopedic implants market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's Five Forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the orthopedic implants market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global orthopedic implants market trends, key players, market segments, application areas, and market growth Strategies.

Key Market Segments

By Product Type

  • Reconstructive Joint Replacements
  • Knee Replacement Implants
  • Hip Replacement Implants
  • Extremities
  • Spinal Implants
  • Spinal fusion implants
  • Invasive Spinal bone stimulators
  • Vertebral Compression Fracture (VCF) Devices
  • Motion Preservation Devices/Non-Fusion Devices
  • Dental Implants
  • Root Form Dental Implants
  • Plate Form Dental Implants
  • Trauma
  • Orthobiologics
  • Demineralized Bone Matrix (DBM)
  • Allograft
  • Bone Morphogenetic Protein (BMP)
  • Viscosupplementation Products
  • Synthetic Bone Substitutes

By Biomaterial

  • Metallic Biomaterials
  • Stainless steel
  • Titanium Alloy
  • Cobalt Alloy
  • Ceramic Biomaterials
  • Polymeric Biomaterials

By Type

  • Wrist and Shoulder
  • Dental
  • Spine
  • Ankle
  • Knee
  • Hip

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • Australia
  • India
  • South Korea
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

Key Market Players

  • Zimmer Biomet Holdings Inc.
  • Arthrex, Inc.
  • Globus Medical, Inc.
  • Medtronic plc
  • Smith & Nephew plc
  • NuVasive Inc.
  • CONMED Corporation
  • Johnson & Johnson
  • Stryker Corporation
  • Colfax Corporation (DJO GLOBAL LLC)

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter’s five forces analysis
3.3.1. Moderate bargaining power of suppliers
3.3.2. High bargaining power of buyers
3.3.3. Moderate threat of substitutes
3.3.4. Moderate threat of new entrants
3.3.5. High intensity of rivalry
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Rise in prevalence of orthopedic disorders
3.4.1.2. Technological advancements in the field of orthopedic implants
3.4.1.3. Surge in demand of orthopedic implants
3.4.2. Restraints
3.4.2.1. High cost of orthopedic implant
3.4.2.2. Complications with implant procedure
3.4.3. Opportunities
3.4.3.1. Growth opportunities in emerging markets
3.5. COVID-19 Impact Analysis on the market

CHAPTER 4: ORTHOPEDIC IMPLANTS MARKET, BY PRODUCT TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Reconstructive Joint Replacements
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.2.4. Reconstructive Joint Replacements Orthopedic Implants Market by Type
4.2.4.1. Extremities Orthopedic Implants Market by Type
4.2.4.1.1. Upper Extremity Reconstruction Orthopedic Implants Market by Type
4.2.4.1.1. Lower Extremity Reconstruction Orthopedic Implants Market by Type
4.3. Spinal Implants
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
4.3.4. Spinal Implants Orthopedic Implants Market by Type
4.3.4.1. Spinal fusion implants Orthopedic Implants Market by Type
4.3.4.2. Vertebral Compression Fracture (VCF) Devices Orthopedic Implants Market by Type
4.3.4.3. Motion Preservation Devices/Non-Fusion Devices Orthopedic Implants Market by Type
4.4. Dental Implants
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market share analysis by country
4.4.4. Dental Implants Orthopedic Implants Market by Type
4.5. Trauma
4.5.1. Key market trends, growth factors and opportunities
4.5.2. Market size and forecast, by region
4.5.3. Market share analysis by country
4.6. Orthobiologics
4.6.1. Key market trends, growth factors and opportunities
4.6.2. Market size and forecast, by region
4.6.3. Market share analysis by country
4.6.4. Orthobiologics Orthopedic Implants Market by Type
4.7. Others
4.7.1. Key market trends, growth factors and opportunities
4.7.2. Market size and forecast, by region
4.7.3. Market share analysis by country

CHAPTER 5: ORTHOPEDIC IMPLANTS MARKET, BY BIOMATERIAL
5.1. Overview
5.1.1. Market size and forecast
5.2. Metallic Biomaterials
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.2.4. Metallic Biomaterials Orthopedic Implants Market by Type
5.3. Ceramic Biomaterials
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
5.4. Polymeric Biomaterials
5.4.1. Key market trends, growth factors and opportunities
5.4.2. Market size and forecast, by region
5.4.3. Market share analysis by country
5.5. Others
5.5.1. Key market trends, growth factors and opportunities
5.5.2. Market size and forecast, by region
5.5.3. Market share analysis by country

CHAPTER 6: ORTHOPEDIC IMPLANTS MARKET, BY TYPE
6.1. Overview
6.1.1. Market size and forecast
6.2. Knee
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market share analysis by country
6.3. Hip
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market share analysis by country
6.4. Wrist and Shoulder
6.4.1. Key market trends, growth factors and opportunities
6.4.2. Market size and forecast, by region
6.4.3. Market share analysis by country
6.5. Dental
6.5.1. Key market trends, growth factors and opportunities
6.5.2. Market size and forecast, by region
6.5.3. Market share analysis by country
6.6. Spine
6.6.1. Key market trends, growth factors and opportunities
6.6.2. Market size and forecast, by region
6.6.3. Market share analysis by country
6.7. Ankle
6.7.1. Key market trends, growth factors and opportunities
6.7.2. Market size and forecast, by region
6.7.3. Market share analysis by country
6.8. Others
6.8.1. Key market trends, growth factors and opportunities
6.8.2. Market size and forecast, by region
6.8.3. Market share analysis by country

CHAPTER 7: ORTHOPEDIC IMPLANTS MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast By Region
7.2. North America
7.2.1. Key trends and opportunities
7.2.2. Market size and forecast, by Product Type
7.2.3. Market size and forecast, by Biomaterial
7.2.4. Market size and forecast, by Type
7.2.5. Market size and forecast, by country
7.2.5.1. U.S.
7.2.5.1.1. Key market trends, growth factors and opportunities
7.2.5.1.2. Market size and forecast, by Product Type
7.2.5.1.3. Market size and forecast, by Biomaterial
7.2.5.1.4. Market size and forecast, by Type
7.2.5.2. Canada
7.2.5.2.1. Key market trends, growth factors and opportunities
7.2.5.2.2. Market size and forecast, by Product Type
7.2.5.2.3. Market size and forecast, by Biomaterial
7.2.5.2.4. Market size and forecast, by Type
7.2.5.3. Mexico
7.2.5.3.1. Key market trends, growth factors and opportunities
7.2.5.3.2. Market size and forecast, by Product Type
7.2.5.3.3. Market size and forecast, by Biomaterial
7.2.5.3.4. Market size and forecast, by Type
7.3. Europe
7.3.1. Key trends and opportunities
7.3.2. Market size and forecast, by Product Type
7.3.3. Market size and forecast, by Biomaterial
7.3.4. Market size and forecast, by Type
7.3.5. Market size and forecast, by country
7.3.5.1. Germany
7.3.5.1.1. Key market trends, growth factors and opportunities
7.3.5.1.2. Market size and forecast, by Product Type
7.3.5.1.3. Market size and forecast, by Biomaterial
7.3.5.1.4. Market size and forecast, by Type
7.3.5.2. France
7.3.5.2.1. Key market trends, growth factors and opportunities
7.3.5.2.2. Market size and forecast, by Product Type
7.3.5.2.3. Market size and forecast, by Biomaterial
7.3.5.2.4. Market size and forecast, by Type
7.3.5.3. UK
7.3.5.3.1. Key market trends, growth factors and opportunities
7.3.5.3.2. Market size and forecast, by Product Type
7.3.5.3.3. Market size and forecast, by Biomaterial
7.3.5.3.4. Market size and forecast, by Type
7.3.5.4. Italy
7.3.5.4.1. Key market trends, growth factors and opportunities
7.3.5.4.2. Market size and forecast, by Product Type
7.3.5.4.3. Market size and forecast, by Biomaterial
7.3.5.4.4. Market size and forecast, by Type
7.3.5.5. Spain
7.3.5.5.1. Key market trends, growth factors and opportunities
7.3.5.5.2. Market size and forecast, by Product Type
7.3.5.5.3. Market size and forecast, by Biomaterial
7.3.5.5.4. Market size and forecast, by Type
7.3.5.6. Rest of Europe
7.3.5.6.1. Key market trends, growth factors and opportunities
7.3.5.6.2. Market size and forecast, by Product Type
7.3.5.6.3. Market size and forecast, by Biomaterial
7.3.5.6.4. Market size and forecast, by Type
7.4. Asia-Pacific
7.4.1. Key trends and opportunities
7.4.2. Market size and forecast, by Product Type
7.4.3. Market size and forecast, by Biomaterial
7.4.4. Market size and forecast, by Type
7.4.5. Market size and forecast, by country
7.4.5.1. Japan
7.4.5.1.1. Key market trends, growth factors and opportunities
7.4.5.1.2. Market size and forecast, by Product Type
7.4.5.1.3. Market size and forecast, by Biomaterial
7.4.5.1.4. Market size and forecast, by Type
7.4.5.2. China
7.4.5.2.1. Key market trends, growth factors and opportunities
7.4.5.2.2. Market size and forecast, by Product Type
7.4.5.2.3. Market size and forecast, by Biomaterial
7.4.5.2.4. Market size and forecast, by Type
7.4.5.3. Australia
7.4.5.3.1. Key market trends, growth factors and opportunities
7.4.5.3.2. Market size and forecast, by Product Type
7.4.5.3.3. Market size and forecast, by Biomaterial
7.4.5.3.4. Market size and forecast, by Type
7.4.5.4. India
7.4.5.4.1. Key market trends, growth factors and opportunities
7.4.5.4.2. Market size and forecast, by Product Type
7.4.5.4.3. Market size and forecast, by Biomaterial
7.4.5.4.4. Market size and forecast, by Type
7.4.5.5. South Korea
7.4.5.5.1. Key market trends, growth factors and opportunities
7.4.5.5.2. Market size and forecast, by Product Type
7.4.5.5.3. Market size and forecast, by Biomaterial
7.4.5.5.4. Market size and forecast, by Type
7.4.5.6. Rest of Asia-Pacific
7.4.5.6.1. Key market trends, growth factors and opportunities
7.4.5.6.2. Market size and forecast, by Product Type
7.4.5.6.3. Market size and forecast, by Biomaterial
7.4.5.6.4. Market size and forecast, by Type
7.5. LAMEA
7.5.1. Key trends and opportunities
7.5.2. Market size and forecast, by Product Type
7.5.3. Market size and forecast, by Biomaterial
7.5.4. Market size and forecast, by Type
7.5.5. Market size and forecast, by country
7.5.5.1. Brazil
7.5.5.1.1. Key market trends, growth factors and opportunities
7.5.5.1.2. Market size and forecast, by Product Type
7.5.5.1.3. Market size and forecast, by Biomaterial
7.5.5.1.4. Market size and forecast, by Type
7.5.5.2. Saudi Arabia
7.5.5.2.1. Key market trends, growth factors and opportunities
7.5.5.2.2. Market size and forecast, by Product Type
7.5.5.2.3. Market size and forecast, by Biomaterial
7.5.5.2.4. Market size and forecast, by Type
7.5.5.3. South Africa
7.5.5.3.1. Key market trends, growth factors and opportunities
7.5.5.3.2. Market size and forecast, by Product Type
7.5.5.3.3. Market size and forecast, by Biomaterial
7.5.5.3.4. Market size and forecast, by Type
7.5.5.4. Rest of LAMEA
7.5.5.4.1. Key market trends, growth factors and opportunities
7.5.5.4.2. Market size and forecast, by Product Type
7.5.5.4.3. Market size and forecast, by Biomaterial
7.5.5.4.4. Market size and forecast, by Type

CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top player positioning, 2022

CHAPTER 9: COMPANY PROFILES
9.1. Arthrex, Inc.
9.1.1. Company overview
9.1.2. Key Executives
9.1.3. Company snapshot
9.1.4. Operating business segments
9.1.5. Product portfolio
9.1.6. Key strategic moves and developments
9.2. Colfax Corporation (DJO GLOBAL LLC)
9.2.1. Company overview
9.2.2. Key Executives
9.2.3. Company snapshot
9.2.4. Operating business segments
9.2.5. Product portfolio
9.2.6. Business performance
9.2.7. Key strategic moves and developments
9.3. CONMED Corporation
9.3.1. Company overview
9.3.2. Key Executives
9.3.3. Company snapshot
9.3.4. Operating business segments
9.3.5. Product portfolio
9.3.6. Business performance
9.3.7. Key strategic moves and developments
9.4. Globus Medical, Inc.
9.4.1. Company overview
9.4.2. Key Executives
9.4.3. Company snapshot
9.4.4. Operating business segments
9.4.5. Product portfolio
9.4.6. Business performance
9.4.7. Key strategic moves and developments
9.5. Johnson & Johnson
9.5.1. Company overview
9.5.2. Key Executives
9.5.3. Company snapshot
9.5.4. Operating business segments
9.5.5. Product portfolio
9.5.6. Business performance
9.5.7. Key strategic moves and developments
9.6. Medtronic plc
9.6.1. Company overview
9.6.2. Key Executives
9.6.3. Company snapshot
9.6.4. Operating business segments
9.6.5. Product portfolio
9.6.6. Business performance
9.6.7. Key strategic moves and developments
9.7. NuVasive Inc.
9.7.1. Company overview
9.7.2. Key Executives
9.7.3. Company snapshot
9.7.4. Operating business segments
9.7.5. Product portfolio
9.7.6. Business performance
9.7.7. Key strategic moves and developments
9.8. Smith & Nephew plc
9.8.1. Company overview
9.8.2. Key Executives
9.8.3. Company snapshot
9.8.4. Operating business segments
9.8.5. Product portfolio
9.8.6. Business performance
9.8.7. Key strategic moves and developments
9.9. Stryker Corporation
9.9.1. Company overview
9.9.2. Key Executives
9.9.3. Company snapshot
9.9.4. Operating business segments
9.9.5. Product portfolio
9.9.6. Business performance
9.9.7. Key strategic moves and developments
9.10. Zimmer Biomet Holdings Inc.
9.10.1. Company overview
9.10.2. Key Executives
9.10.3. Company snapshot
9.10.4. Operating business segments
9.10.5. Product portfolio
9.10.6. Business performance
9.10.7. Key strategic moves and developments

List of Tables
Table 01. Global Orthopedic Implants Market, by Product Type, 2022-2032 (Revenue, $Million)
Table 02. Orthopedic Implants Market for Reconstructive Joint Replacements, by Region, 2022-2032 (Revenue, $Million)
Table 03. Global Reconstructive Joint Replacements Orthopedic Implants Market, by Type, 2022-2032 (Revenue, $Million)
Table 04. Global Extremities Orthopedic Implants Market, by Type, 2022-2032 (Revenue, $Million)
Table 05. Global Upper Extremity Reconstruction Orthopedic Implants Market, by Type, 2022-2032 (Revenue, $Million)
Table 06. Global Lower Extremity Reconstruction Orthopedic Implants Market, by Type, 2022-2032 (Revenue, $Million)
Table 07. Orthopedic Implants Market for Spinal Implants, by Region, 2022-2032 (Revenue, $Million)
Table 08. Global Spinal Implants Orthopedic Implants Market, by Type, 2022-2032 (Revenue, $Million)
Table 09. Global Spinal Fusion Implants Orthopedic Implants Market, by Type, 2022-2032 (Revenue, $Million)
Table 10. Global Vertebral Compression Fracture (Vcf) Devices Orthopedic Implants Market, by Type, 2022-2032 (Revenue, $Million)
Table 11. Global Motion Preservation Devices/Non-Fusion Devices Orthopedic Implants Market, by Type, 2022-2032 (Revenue, $Million)
Table 12. Orthopedic Implants Market for Dental Implants, by Region, 2022-2032 (Revenue, $Million)
Table 13. Global Dental Implants Orthopedic Implants Market, by Type, 2022-2032 (Revenue, $Million)
Table 14. Orthopedic Implants Market for Trauma, by Region, 2022-2032 (Revenue, $Million)
Table 15. Orthopedic Implants Market for Orthobiologics, by Region, 2022-2032 (Revenue, $Million)
Table 16. Global Orthobiologics Orthopedic Implants Market, by Type, 2022-2032 (Revenue, $Million)
Table 17. Orthopedic Implants Market for Others, by Region, 2022-2032 (Revenue, $Million)
Table 18. Global Orthopedic Implants Market, by Biomaterial, 2022-2032 (Revenue, $Million)
Table 19. Orthopedic Implants Market for Metallic Biomaterials, by Region, 2022-2032 (Revenue, $Million)
Table 20. Global Metallic Biomaterials Orthopedic Implants Market, by Type, 2022-2032 (Revenue, $Million)
Table 21. Orthopedic Implants Market for Ceramic Biomaterials, by Region, 2022-2032 (Revenue, $Million)
Table 22. Orthopedic Implants Market for Polymeric Biomaterials, by Region, 2022-2032 (Revenue, $Million)
Table 23. Orthopedic Implants Market for Others, by Region, 2022-2032 (Revenue, $Million)
Table 24. Global Orthopedic Implants Market, by Type, 2022-2032 (Revenue, $Million)
Table 25. Orthopedic Implants Market for Knee, by Region, 2022-2032 (Revenue, $Million)
Table 26. Orthopedic Implants Market for Hip, by Region, 2022-2032 (Revenue, $Million)
Table 27. Orthopedic Implants Market for Wrist and Shoulder, by Region, 2022-2032 (Revenue, $Million)
Table 28. Orthopedic Implants Market for Dental, by Region, 2022-2032 (Revenue, $Million)
Table 29. Orthopedic Implants Market for Spine, by Region, 2022-2032 (Revenue, $Million)
Table 30. Orthopedic Implants Market for Ankle, by Region, 2022-2032 (Revenue, $Million)
Table 31. Orthopedic Implants Market for Others, by Region, 2022-2032 (Revenue, $Million)
Table 32. Orthopedic Implants Market, by Region, 2022-2032 (Revenue, $Million)
Table 33. North America Orthopedic Implants Market, by Product Type, 2022-2032 (Revenue, $Million)
Table 34. North America Orthopedic Implants Market, by Biomaterial, 2022-2032 (Revenue, $Million)
Table 35. North America Orthopedic Implants Market, by Type, 2022-2032 (Revenue, $Million)
Table 36. North America Orthopedic Implants Market, by Country, 2022-2032 (Revenue, $Million)
Table 37. U.S. Orthopedic Implants Market, by Product Type, 2022-2032 (Revenue, $Million)
Table 38. U.S. Orthopedic Implants Market, by Biomaterial, 2022-2032 (Revenue, $Million)
Table 39. U.S. Orthopedic Implants Market, by Type, 2022-2032 (Revenue, $Million)
Table 40. Canada Orthopedic Implants Market, by Product Type, 2022-2032 (Revenue, $Million)
Table 41. Canada Orthopedic Implants Market, by Biomaterial, 2022-2032 (Revenue, $Million)
Table 42. Canada Orthopedic Implants Market, by Type, 2022-2032 (Revenue, $Million)
Table 43. Mexico Orthopedic Implants Market, by Product Type, 2022-2032 (Revenue, $Million)
Table 44. Mexico Orthopedic Implants Market, by Biomaterial, 2022-2032 (Revenue, $Million)
Table 45. Mexico Orthopedic Implants Market, by Type, 2022-2032 (Revenue, $Million)
Table 46. Europe Orthopedic Implants Market, by Product Type, 2022-2032 (Revenue, $Million)
Table 47. Europe Orthopedic Implants Market, by Biomaterial, 2022-2032 (Revenue, $Million)
Table 48. Europe Orthopedic Implants Market, by Type, 2022-2032 (Revenue, $Million)
Table 49. Europe Orthopedic Implants Market, by Country, 2022-2032 (Revenue, $Million)
Table 50. Germany Orthopedic Implants Market, by Product Type, 2022-2032 (Revenue, $Million)
Table 51. Germany Orthopedic Implants Market, by Biomaterial, 2022-2032 (Revenue, $Million)
Table 52. Germany Orthopedic Implants Market, by Type, 2022-2032 (Revenue, $Million)
Table 53. France Orthopedic Implants Market, by Product Type, 2022-2032 (Revenue, $Million)
Table 54. France Orthopedic Implants Market, by Biomaterial, 2022-2032 (Revenue, $Million)
Table 55. France Orthopedic Implants Market, by Type, 2022-2032 (Revenue, $Million)
Table 56. UK Orthopedic Implants Market, by Product Type, 2022-2032 (Revenue, $Million)
Table 57. UK Orthopedic Implants Market, by Biomaterial, 2022-2032 (Revenue, $Million)
Table 58. UK Orthopedic Implants Market, by Type, 2022-2032 (Revenue, $Million)
Table 59. Italy Orthopedic Implants Market, by Product Type, 2022-2032 (Revenue, $Million)
Table 60. Italy Orthopedic Implants Market, by Biomaterial, 2022-2032 (Revenue, $Million)
Table 61. Italy Orthopedic Implants Market, by Type, 2022-2032 (Revenue, $Million)
Table 62. Spain Orthopedic Implants Market, by Product Type, 2022-2032 (Revenue, $Million)
Table 63. Spain Orthopedic Implants Market, by Biomaterial, 2022-2032 (Revenue, $Million)
Table 64. Spain Orthopedic Implants Market, by Type, 2022-2032 (Revenue, $Million)
Table 65. Rest of Europe Orthopedic Implants Market, by Product Type, 2022-2032 (Revenue, $Million)
Table 66. Rest of Europe Orthopedic Implants Market, by Biomaterial, 2022-2032 (Revenue, $Million)
Table 67. Rest of Europe Orthopedic Implants Market, by Type, 2022-2032 (Revenue, $Million)
Table 68. Asia-Pacific Orthopedic Implants Market, by Product Type, 2022-2032 (Revenue, $Million)
Table 69. Asia-Pacific Orthopedic Implants Market, by Biomaterial, 2022-2032 (Revenue, $Million)
Table 70. Asia-Pacific Orthopedic Implants Market, by Type, 2022-2032 (Revenue, $Million)
Table 71. Asia-Pacific Orthopedic Implants Market, by Country, 2022-2032 (Revenue, $Million)
Table 72. Japan Orthopedic Implants Market, by Product Type, 2022-2032 (Revenue, $Million)
Table 73. Japan Orthopedic Implants Market, by Biomaterial, 2022-2032 (Revenue, $Million)
Table 74. Japan Orthopedic Implants Market, by Type, 2022-2032 (Revenue, $Million)
Table 75. China Orthopedic Implants Market, by Product Type, 2022-2032 (Revenue, $Million)
Table 76. China Orthopedic Implants Market, by Biomaterial, 2022-2032 (Revenue, $Million)
Table 77. China Orthopedic Implants Market, by Type, 2022-2032 (Revenue, $Million)
Table 78. Australia Orthopedic Implants Market, by Product Type, 2022-2032 (Revenue, $Million)
Table 79. Australia Orthopedic Implants Market, by Biomaterial, 2022-2032 (Revenue, $Million)
Table 80. Australia Orthopedic Implants Market, by Type, 2022-2032 (Revenue, $Million)
Table 81. India Orthopedic Implants Market, by Product Type, 2022-2032 (Revenue, $Million)
Table 82. India Orthopedic Implants Market, by Biomaterial, 2022-2032 (Revenue, $Million)
Table 83. India Orthopedic Implants Market, by Type, 2022-2032 (Revenue, $Million)
Table 84. South Korea Orthopedic Implants Market, by Product Type, 2022-2032 (Revenue, $Million)
Table 85. South Korea Orthopedic Implants Market, by Biomaterial, 2022-2032 (Revenue, $Million)
Table 86. South Korea Orthopedic Implants Market, by Type, 2022-2032 (Revenue, $Million)
Table 87. Rest of Asia-Pacific Orthopedic Implants Market, by Product Type, 2022-2032 (Revenue, $Million)
Table 88. Rest of Asia-Pacific Orthopedic Implants Market, by Biomaterial, 2022-2032 (Revenue, $Million)
Table 89. Rest of Asia-Pacific Orthopedic Implants Market, by Type, 2022-2032 (Revenue, $Million)
Table 90. LAMEA Orthopedic Implants Market, by Product Type, 2022-2032 (Revenue, $Million)
Table 91. LAMEA Orthopedic Implants Market, by Biomaterial, 2022-2032 (Revenue, $Million)
Table 92. LAMEA Orthopedic Implants Market, by Type, 2022-2032 (Revenue, $Million)
Table 93. LAMEA Orthopedic Implants Market, by Country, 2022-2032 (Revenue, $Million)
Table 94. Brazil Orthopedic Implants Market, by Product Type, 2022-2032 (Revenue, $Million)
Table 95. Brazil Orthopedic Implants Market, by Biomaterial, 2022-2032 (Revenue, $Million)
Table 96. Brazil Orthopedic Implants Market, by Type, 2022-2032 (Revenue, $Million)
Table 97. Saudi Arabia Orthopedic Implants Market, by Product Type, 2022-2032 (Revenue, $Million)
Table 98. Saudi Arabia Orthopedic Implants Market, by Biomaterial, 2022-2032 (Revenue, $Million)
Table 99. Saudi Arabia Orthopedic Implants Market, by Type, 2022-2032 (Revenue, $Million)
Table 100. South Africa Orthopedic Implants Market, by Product Type, 2022-2032 (Revenue, $Million)
Table 101. South Africa Orthopedic Implants Market, by Biomaterial, 2022-2032 (Revenue, $Million)
Table 102. South Africa Orthopedic Implants Market, by Type, 2022-2032 (Revenue, $Million)
Table 103. Rest of LAMEA Orthopedic Implants Market, by Product Type, 2022-2032 (Revenue, $Million)
Table 104. Rest of LAMEA Orthopedic Implants Market, by Biomaterial, 2022-2032 (Revenue, $Million)
Table 105. Rest of LAMEA Orthopedic Implants Market, by Type, 2022-2032 (Revenue, $Million)
Table 106. Arthrex, Inc.: Key Executives
Table 107. Arthrex, Inc.: Company Snapshot
Table 108. Arthrex, Inc.: Product Segments
Table 109. Arthrex, Inc.: Product Portfolio
Table 110. Arthrex, Inc.: Key Strategies
Table 111. Colfax Corporation (Djo Global LLC): Key Executives
Table 112. Colfax Corporation (Djo Global LLC): Company Snapshot
Table 113. Colfax Corporation (Djo Global LLC): Product Segments
Table 114. Colfax Corporation (Djo Global LLC): Product Portfolio
Table 115. Colfax Corporation (Djo Global LLC): Key Strategies
Table 116. Conmed Corporation: Key Executives
Table 117. Conmed Corporation: Company Snapshot
Table 118. Conmed Corporation: Product Segments
Table 119. Conmed Corporation: Product Portfolio
Table 120. Conmed Corporation: Key Strategies
Table 121. Globus Medical, Inc.: Key Executives
Table 122. Globus Medical, Inc.: Company Snapshot
Table 123. Globus Medical, Inc.: Product Segments
Table 124. Globus Medical, Inc.: Product Portfolio
Table 125. Globus Medical, Inc.: Key Strategies
Table 126. Johnson & Johnson: Key Executives
Table 127. Johnson & Johnson: Company Snapshot
Table 128. Johnson & Johnson: Product Segments
Table 129. Johnson & Johnson: Product Portfolio
Table 130. Johnson & Johnson: Key Strategies
Table 131. Medtronic PLC: Key Executives
Table 132. Medtronic PLC: Company Snapshot
Table 133. Medtronic PLC: Product Segments
Table 134. Medtronic PLC: Product Portfolio
Table 135. Medtronic PLC: Key Strategies
Table 136. Nuvasive Inc.: Key Executives
Table 137. Nuvasive Inc.: Company Snapshot
Table 138. Nuvasive Inc.: Product Segments
Table 139. Nuvasive Inc.: Product Portfolio
Table 140. Nuvasive Inc.: Key Strategies
Table 141. Smith & Nephew PLC: Key Executives
Table 142. Smith & Nephew PLC: Company Snapshot
Table 143. Smith & Nephew PLC: Product Segments
Table 144. Smith & Nephew PLC: Product Portfolio
Table 145. Smith & Nephew PLC: Key Strategies
Table 146. Stryker Corporation: Key Executives
Table 147. Stryker Corporation: Company Snapshot
Table 148. Stryker Corporation: Product Segments
Table 149. Stryker Corporation: Product Portfolio
Table 150. Stryker Corporation: Key Strategies
Table 151. Zimmer Biomet Holdings Inc.: Key Executives
Table 152. Zimmer Biomet Holdings Inc.: Company Snapshot
Table 153. Zimmer Biomet Holdings Inc.: Product Segments
Table 154. Zimmer Biomet Holdings Inc.: Product Portfolio
Table 155. Zimmer Biomet Holdings Inc.: Key Strategies

List of Figures
Figure 01. Orthopedic Implants Market, 2022-2032
Figure 02. Segmentation of Orthopedic Implants Market, 2022-2032
Figure 03. Top Investment Pockets in Orthopedic Implants Market (2023-2032)
Figure 04. Moderate Bargaining Power of Suppliers
Figure 05. High Bargaining Power of Buyers
Figure 06. Moderate Threat of Substitutes
Figure 07. Moderate Threat of New Entrants
Figure 08. High Intensity of Rivalry
Figure 09. Drivers, Restraints and Opportunities: Globalorthopedic Implants Market
Figure 10. Orthopedic Implants Market, by Product Type, 2022(%)
Figure 11. Comparative Share Analysis of Orthopedic Implants Market for Reconstructive Joint Replacements, by Country 2022-2032(%)
Figure 12. Comparative Share Analysis of Orthopedic Implants Market for Spinal Implants, by Country 2022-2032(%)
Figure 13. Comparative Share Analysis of Orthopedic Implants Market for Dental Implants, by Country 2022-2032(%)
Figure 14. Comparative Share Analysis of Orthopedic Implants Market for Trauma, by Country 2022-2032(%)
Figure 15. Comparative Share Analysis of Orthopedic Implants Market for Orthobiologics, by Country 2022-2032(%)
Figure 16. Comparative Share Analysis of Orthopedic Implants Market for Others, by Country 2022-2032(%)
Figure 17. Orthopedic Implants Market, by Biomaterial, 2022(%)
Figure 18. Comparative Share Analysis of Orthopedic Implants Market for Metallic Biomaterials, by Country 2022-2032(%)
Figure 19. Comparative Share Analysis of Orthopedic Implants Market for Ceramic Biomaterials, by Country 2022-2032(%)
Figure 20. Comparative Share Analysis of Orthopedic Implants Market for Polymeric Biomaterials, by Country 2022-2032(%)
Figure 21. Comparative Share Analysis of Orthopedic Implants Market for Others, by Country 2022-2032(%)
Figure 22. Orthopedic Implants Market, by Type, 2022(%)
Figure 23. Comparative Share Analysis of Orthopedic Implants Market for Knee, by Country 2022-2032(%)
Figure 24. Comparative Share Analysis of Orthopedic Implants Market for Hip, by Country 2022-2032(%)
Figure 25. Comparative Share Analysis of Orthopedic Implants Market for Wrist and Shoulder, by Country 2022-2032(%)
Figure 26. Comparative Share Analysis of Orthopedic Implants Market for Dental, by Country 2022-2032(%)
Figure 27. Comparative Share Analysis of Orthopedic Implants Market for Spine, by Country 2022-2032(%)
Figure 28. Comparative Share Analysis of Orthopedic Implants Market for Ankle, by Country 2022-2032(%)
Figure 29. Comparative Share Analysis of Orthopedic Implants Market for Others, by Country 2022-2032(%)
Figure 30. Orthopedic Implants Market by Region, 2022
Figure 31. U.S. Orthopedic Implants Market, 2022-2032 ($Million)
Figure 32. Canada Orthopedic Implants Market, 2022-2032 ($Million)
Figure 33. Mexico Orthopedic Implants Market, 2022-2032 ($Million)
Figure 34. Germany Orthopedic Implants Market, 2022-2032 ($Million)
Figure 35. France Orthopedic Implants Market, 2022-2032 ($Million)
Figure 36. UK Orthopedic Implants Market, 2022-2032 ($Million)
Figure 37. Italy Orthopedic Implants Market, 2022-2032 ($Million)
Figure 38. Spain Orthopedic Implants Market, 2022-2032 ($Million)
Figure 39. Rest of Europe Orthopedic Implants Market, 2022-2032 ($Million)
Figure 40. Japan Orthopedic Implants Market, 2022-2032 ($Million)
Figure 41. China Orthopedic Implants Market, 2022-2032 ($Million)
Figure 42. Australia Orthopedic Implants Market, 2022-2032 ($Million)
Figure 43. India Orthopedic Implants Market, 2022-2032 ($Million)
Figure 44. South Korea Orthopedic Implants Market, 2022-2032 ($Million)
Figure 45. Rest of Asia-Pacific Orthopedic Implants Market, 2022-2032 ($Million)
Figure 46. Brazil Orthopedic Implants Market, 2022-2032 ($Million)
Figure 47. Saudi Arabia Orthopedic Implants Market, 2022-2032 ($Million)
Figure 48. South Africa Orthopedic Implants Market, 2022-2032 ($Million)
Figure 49. Rest of LAMEA Orthopedic Implants Market, 2022-2032 ($Million)
Figure 50. Top Winning Strategies, by Year
Figure 51. Top Winning Strategies, by Development
Figure 52. Top Winning Strategies, by Company
Figure 53. Product Mapping of Top 10 Players
Figure 54. Competitive Dashboard
Figure 55. Competitive Heatmap: Orthopedic Implants Market
Figure 56. Top Player Positioning, 2022
Figure 57. Colfax Corporation (Djo Global LLC): Net Sales, 2019-2021 ($Million)
Figure 58. Colfax Corporation (Djo Global LLC): Revenue Share by Segment, 2021 (%)
Figure 59. Colfax Corporation (Djo Global LLC): Revenue Share by Region, 2021 (%)
Figure 60. Conmed Corporation: Net Sales, 2019-2021 ($Million)
Figure 61. Conmed Corporation: Revenue Share by Segment, 2021 (%)
Figure 62. Conmed Corporation: Revenue Share by Region, 2021 (%)
Figure 63. Globus Medical, Inc.: Net Sales, 2019-2021 ($Million)
Figure 64. Globus Medical, Inc.: Revenue Share by Segment, 2021 (%)
Figure 65. Globus Medical, Inc.: Revenue Share by Region, 2021 (%)
Figure 66. Johnson & Johnson: Net Revenue, 2019-2021 ($Million)
Figure 67. Johnson & Johnson: Revenue Share by Segment, 2021 (%)
Figure 68. Johnson & Johnson: Revenue Share by Region, 2021 (%)
Figure 69. Medtronic PLC: Net Sales, 2020-2022 ($Million)
Figure 70. Medtronic PLC: Revenue Share by Segment, 2022 (%)
Figure 71. Medtronic PLC: Revenue Share by Region, 2022 (%)
Figure 72. Nuvasive Inc.: Net Sales, 2019-2021 ($Million)
Figure 73. Nuvasive Inc.: Revenue Share by Segment, 2021 (%)
Figure 74. Nuvasive Inc.: Revenue Share by Region, 2021 (%)
Figure 75. Smith & Nephew PLC: Net Revenue, 2019-2021 ($Million)
Figure 76. Smith & Nephew PLC: Revenue Share by Segment, 2021 (%)
Figure 77. Smith & Nephew PLC: Revenue Share by Region, 2021 (%)
Figure 78. Stryker Corporation: Net Revenue, 2019-2021 ($Million)
Figure 79. Stryker Corporation: Revenue Share by Segment, 2021 (%)
Figure 80. Stryker Corporation: Revenue Share by Region, 2021 (%)
Figure 81. Zimmer Biomet Holdings Inc.: Net Sales, 2019-2021 ($Million)
Figure 82. Zimmer Biomet Holdings Inc.: Revenue Share by Segment, 2021 (%)
Figure 83. Zimmer Biomet Holdings Inc.: Revenue Share by Region, 2021 (%)

Executive Summary

According to the report titled, 'Orthopedic Implants Market,' the orthopedic implants market was valued at $47,190.57 million in 2022 and is estimated to reach $73,326.75 million by 2032, growing at a CAGR of 4.5% from 2023 to 2032. Orthopedic implants are devices that are placed inside or on the surface of the body, intended to replace missing body parts or provide support to organs and tissues. The use of orthopedic implants helps to improve mobility, reduce pain and improve overall quality of life of patients. The orthopedic implants are designed to mimic the function and movement of the natural joint or bone as closely as possible and are typically made from biocompatible materials to minimize the risk of infection.

Key factors driving the growth of the orthopedic implants market are rise in prevalence of bone and joint problems such as osteoarthritis, presence of major key players offering orthopedic implants, increase in number of sport-related injuries and rise in technological advancements in orthopedic implants. The rise in prevalence of orthopedic disorders and sport-related injury are major factors that fuel the orthopedic implant market. For instance, a National Cricket Academy Injury Surveillance Report 2021 stated that, in India, rise in prevalence of sport related injuries was observed accounting for 14.75% (shoulder injuries) and 13.11% (knee injuries). In the UK, the rise in the number of knee replacement surgeries is the major factor contributing to the growth of the market. For instance, an article of National Health Service 2022 reported that 70,000 knee replacement surgeries are carried out every year, thus rise in number of surgeries drives the growth of market.

Further, geriatric population is prone to many orthopedic disorders such as arthritis, back pain, and neck pain, which results in demand for orthopedic implant. Thus, rise in geriatric population is expected to contribute to the growth of the orthopedic implant market. For instance, data by the World Health Organization (WHO) 2021 stated that 1.4 billion of the world’s population is aged 60 years and over and is expected to double by 2050. In addition, a rise in the number of hip and knee fractures across the globe results in demand for orthopedic implants and thus, contributes to the market expansion.

The rise in the number of product launches and the presence of key players offering advanced orthopedic implants are the factors contributing to the growth of the market. For instance, in March 2022, Stryker Corporation launched Insignia Hip Stem, an engineered implant which eases the surgeon’s process in muscle-sparing approaches for total hip and hemiarthroplasty procedures. Thus, the rise in new product launches by key players is driving the growth of the segment.

The market also offers growth opportunities to the key players in the market. Many developing regions such India and Brazil offer lucrative opportunities to key players of orthopedic implants market owing to high population base, increase in demand of advanced orthopedic implants and increase in healthcare spending. In addition, government initiatives regarding orthopedic implants in various countries and medical tourism fuels the growth of market.

The global orthopedic implants market is segmented into product, biomaterial, type and region. On the basis of product, the market is categorized into reconstructive joint replacements, spinal implants, dental implants, trauma, orthobiologics, and others. The reconstructive joint replacements segment is segmented into knee replacement implants, hip replacement implants, and extremities that include upper extremity reconstruction and lower extremity reconstruction. In addition, spinal implants segment is further divided into spinal fusion implants, vertebral compression fracture (VCF) devices, and motion preservation devices/non-fusion devices. Furthermore, dental implants are again classified into root form dental implants and plate form dental implants. Moreover, orthobiologics is further segmented into demineralized bone matrix (DBM), allograft, bone morphogenetic protein (BMP), viscosupplementation products, synthetic bone substitutes, and others.

On the basis of biomaterial, the market is categorized into metallic biomaterials, ceramic biomaterials, polymers biomaterials, and others. On the basis of type, the market is classified into knee, hip, wrist & shoulder, dental, spine, ankle, and others. Region wise, the market is analyzed across North America ( U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

The key players profiled in the study include Arthrex, Inc., Colfax Corporation (DJO, LLC), CONMED CORPORATION, GLOBUS MEDICAL INC., Johnson & Johnson (DEPUY SYNTHES), Medtronic Plc, NuVasive Inc., Smith & Nephew plc, Stryker Corporation, and Zimmer Biomet Holdings Inc. The players in the market have been actively engaged in the adoption various Strategies such as agreement, acquisition, collaboration, innovation, product approval, product launch, partnership and contract to remain competitive and gain advantage over the competitors in the market. For instance, in November 2022, Arthrex and Richard Wolf, global leaders in minimally invasive surgical technology and solutions, announced a U.S.-based partnership to offer comprehensive technology and product offerings in urology, gynecology and general surgery.

Key Market Insights

  • Based on product, the reconstructive joint replacements held the largest share in the global market in 2022.
  • Based on type, the knee segment held the largest market share in 2022 and is expected to remain dominant during the forecast period.
  • By biomaterial, the metallic biomaterial dominated the global market in 2022 and is anticipated to continue this trend during the forecast period.
  • By region, North America generated the highest revenue in 2022. However, Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.

Companies Mentioned

  • Zimmer Biomet Holdings Inc.
  • Arthrex, Inc.
  • Globus Medical, Inc.
  • Medtronic plc
  • Smith & Nephew plc
  • NuVasive Inc.
  • CONMED Corporation
  • Johnson & Johnson
  • Stryker Corporation
  • Colfax Corporation (DJO GLOBAL LLC)

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...